Infection Prevention for Multiple Myeloma Patients
1New tailored prevention reduces infection risk in antibody therapy.
2Specific management includes immunoglobulin based on immune status.
3Patients can now receive safer treatment with fewer complications.
📖 Easy Explanation
🔍 Background
Multiple myeloma is a blood cancer often treated with effective antibodies. However, these treatments also reduce healthy immune cells, increasing infection risk.
📌 Key Points
Korean doctors established clear criteria for when to provide immune supplements based on individual blood levels, ensuring personalized care.
💡 Why It Matters
This strategy helps prevent dangerous infections during cancer treatment, allowing patients and families to focus on recovery with less worry.
📚 Glossary
CD38 항체 (CD38 Hangche)Targeted cancer drug component that attacks specific proteins on cancer cells.
다발성골수종 (Dabalseong Golsujong)A type of blood cancer where plasma cells grow abnormally.
면역글로불린 (Myeon-yeok Geullobullin)Immune proteins that protect the body from bacteria and viruses.